Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL): Managing New and Current Patients, Reducing Risk

Please join us as experts Dr. William P. Adams, Jr, Dr. Caroline A. Glicksman, and Dr. Patricia A. McGuire discuss Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL).

First recognized by the World Health Organization in 2016, most cases of BIA-ALCL are curable given early detection and proper treatment. This CME-accredited activity was designed to help educate clinicians in plastic surgery and primary care about the diagnosis, staging, and optimal treatment of BIA-ALCL, as well as how to educate patients who have breast implants or are considering getting them about the risk of BIA-ALCL and the importance of early detection and appropriate treatment.

Time:
8:00 PM – 9:30 PM ET
7:00 PM – 8:30 PM CT
5:00 PM – 6:30 PM PT